Finance

Lists
VIVIMEDLAB:NSE
Vivimed Labs Ltd
₹6.67
+1.99%
(+0.13) 1D
Sep 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for VIVIMEDLAB...
Open
₹6.41
High
₹6.67
Low
₹6.41
Mkt. cap
545.57M
Avg. vol.
0.00
Volume
211.25K
52-wk high
₹29.40
52-wk low
₹4.75
EPS
-₹21.15
Shares outstanding
82.52M
No. of employees
586
Open
₹6.41
High
₹6.67
Low
₹6.41
Mkt. cap
545.57M
Avg. vol.
0.00
Volume
211.25K
52-wk high
₹29.40
52-wk low
₹4.75
EPS
-₹21.15
Shares outstanding
82.52M
No. of employees
586
Profile
Vivimed Labs Limited is an India-based global supplier of specialty chemicals and pharmaceuticals. Headquartered in Hyderabad, India. Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics. Wikipedia
About Vivimed Labs Ltd
CEO-
Employees586
Founded1988
HeadquartersHyderabad, Andhra Pradesh, India
SectorPharmaceutical industry
Websitevivimedlabs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
217.66M
208.24M
159.89M
177.47M
Cost of goods sold
97.98M
91.18M
78.98M
469.33M
Cost of revenue
97.98M
91.18M
78.98M
469.33M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57.05M
55.96M
36.95M
99.70M
Operating expense
168.85M
173.53M
236.41M
1.17B
Total operating expenses
266.83M
264.71M
315.39M
1.64B
Operating income
-49.17M
-56.47M
-155.50M
-1.46B
Other non operating income
-
10.00K
-
-
EBT including unusual items
-54.93M
-73.01M
-165.54M
-1.47B
EBT excluding unusual items
-54.93M
-73.01M
-165.54M
-1.47B
Income tax expense
-
-
-
1.37M
Effective tax rate
-
-
-
-0.09%
Other operating expenses
61.67M
68.53M
153.18M
953.76M
Net income
-54.93M
-73.01M
-165.54M
-1.47B
Net profit margin
-25.24%
-35.06%
-103.53%
-829.00%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-5.76M
-16.55M
-10.04M
-9.47M
Net interest expenses
-5.76M
-16.55M
-10.04M
-9.47M
Depreciation and amortization charges
50.13M
49.04M
46.28M
115.07M
EBITDA
1.39M
-6.88M
-104.94M
-1.40B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps